SCHEMBL6021743

SCHEMBL6021743

O=C(NS(=O)(=O)Cc1ccc(S(=O)(=O)N2CCN(CC(=O)N3CCOCC3)CC2)s1)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 6/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ NPC1 O15118 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ CTDSP1 Q9GZU7 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ APEX1 P27695 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ MAPK10 P53779 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2428407 0.88 MAPK9 (0.53) POLBSMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL7435212 0.81 MAPK9 (0.48) POLBSMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL2423853 0.80 MAPK9 (0.54) POLBSMN1; SMN2ALDH1A1LMNAMEN1
SCHEMBL4965751 0.76 SMN1; SMN2 (0.53) POLBSMN1; SMN2ALDH1A1LMNAMEN1
SCHEMBL3479993 0.72 MAPK9 (0.51) POLBSMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL5564833 0.71 ALDH1A1 (0.44) POLBSMN1; SMN2ALDH1A1LMNAMEN1
SCHEMBL7894669 0.70 MAPK9 (0.59) POLBALDH1A1LMNAMEN1KMT2A
SCHEMBL6431701 0.70 MAPK9 (0.59) POLBALDH1A1LMNAMEN1KMT2A
SCHEMBL2423054 0.70 MAPK9 (0.59) POLBSMN1; SMN2ALDH1A1LMNAMEN1
SCHEMBL3480648 0.69 MAPK9 (0.60) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663193-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES Applied Research Systems ARS Holding N.V. (AN) 2006-06-07 — — EP disclosed
WO-2005025558-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES APPLIED RESERACH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 — — WO disclosed
Send feedback